Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy

NCT00469911 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-09-13

Study results available
· View outcomes & findings →

Summary

Accumulation of triglycerides in heart tissue has been associated with changes in left ventricular function which can lead to heart failure. Proton magnetic resonance spectroscopy is currently the only non-invasive in vivo method to measure myocardial triglycerides content. The primary goal of this study was to determine if Magnetic Resonance Spectroscopy could effectively measure myocardial triglyceride content in myocardial heart tissue. Thus, quantitative and reliable techniques to monitor in vivo triglyceride accumulation in the heart are important for disease diagnosis and management. Currently, no such imaging method exists.

Conditions

  • Heart Transplantation

Interventions

PROCEDURE

Magnetic Resonance Spectroscopy

Magnetic Resonance Spectroscopy is a noninvasive procedure that provides detailed body images on any plane.

PROCEDURE

Ex vivo heart biopsy

Heart transplant patients will have their normal clinical routine heart biopsy

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Center for Research Resources (NCRR)

    collaborator NIH
  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Robert Gropler, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469911 on ClinicalTrials.gov